Should Zelen pre-randomised consent designs be used in some neonatal trials?

ALLMARK, P. J. (1999). Should Zelen pre-randomised consent designs be used in some neonatal trials? Journal of medical ethics, 25, 325-329.

Full text not available from this repository.
Link to published version:: https://doi.org/10.1136/jme.25.4.325
Related URLs:

    Abstract

    My aim is to suggest that there is a case for using a randomised consent design in some neonatal trials. As an example I use the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. In some trials the process of obtaining consent has the potential to harm the subject, for example, by disappointing those who end in the control group and by creating additional anxiety at times of acute illness. An example of such were the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. Pre-randomised consent could avoid or lessen these harms. However, a number of ethical objections are made to these research designs. They involve denial of information, using people, denial of choice, and 'overselling' of allocated treatment. Furthermore, they are the wrong response; better communication might be the answer, for example. I argue that these objections are not completely persuasive. However, they are enough to suggest caution in the use of such designs.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Centre for Health and Social Care Research
    Identification Number: https://doi.org/10.1136/jme.25.4.325
    Page Range: 325-329
    Depositing User: Caroline Fixter
    Date Deposited: 29 Apr 2010 15:48
    Last Modified: 18 Mar 2021 09:30
    URI: http://shura.shu.ac.uk/id/eprint/1743

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics